QNCX
Quince Therapeutics·NASDAQ
--
--(--)
--
--(--)
Quince Therapeutics (QNCX) Financials Overview
Quince Therapeutics (QNCX) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -68 (YoY +46.88%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-68
+46.88%
Report date
Aug 11, 2025
Earnings Call
4:00 PM on Aug 11, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Quince Therapeutics (QNCX) key financial stats and ratios, covering profitability, financial health, and leverage.
Quince Therapeutics (QNCX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Quince Therapeutics (QNCX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Quince Therapeutics (QNCX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Quince Therapeutics (QNCX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Quince Therapeutics (QNCX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
More Financial Metrics
You can ask Aime
Did Quince Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Quince Therapeutics's earnings call?What factors drove the changes in Quince Therapeutics's revenue and profit?What is the market's earnings forecast for Quince Therapeutics next quarter?What is Quince Therapeutics's gross profit margin?What is Quince Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Quince Therapeutics’s earnings call?What does Quince Therapeutics do and what are its main business segments?
